Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 520 participants.

Also called NCT07908875

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 520 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07908875
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07908875. Randomized; single masking; primary purpose treatment. Start 2026-11-30 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
Condition
Ischemia Stroke
Intervention (Drug)
Atorvastatin
Intervention (Drug)
Hybutimibe 10mg QD
Lead sponsor
First Affiliated Hospital of Wannan Medical College (class: other)

Record details

Record id
cardio:ct-nct07908875
Content hash
7fff621de62c54faa0e868521638f7212663a793a022d7a0c84f4a82aaffca30